Join CBSET at PCR Innovators Day, May 18, 2026 , at the Palais des Congrès de Paris, Paris France. This educational course is designed to help innovators keep ahead of what’s next in cardiovascular innovation, from breakthrough technologies to practical implementation. It will be a day of bold ideas, fresh perspectives, and real-world innovation.
Meet with CBSET executives to learn about CBSET's Corporate Residency Program
Michael C. John, CBSET Chief Regulatory and Innovation Officer (CRIO)
PROGRAM ELEMENTS
Physical Office Space
- Dedicated workspace for staff, enabling day-to-day operations, collaboration, and proximity to customers
Priority Access to Operating Rooms and Analytical Testing Labs
- Reserved timeslots in operating rooms (ORs) and analytical labs, ensures rapid initiation of studies
Access to Expansive Medtech network
- Facilitated introductions to clinicians, KOLs, investors, and strategic partners
- Curated access to CROs, testing labs, manufacturing partners, and consultants
- Association with a recognized network enhances perceived legitimacy with investors, partners, and customers often improving fundraising outcomes and partnership opportunities.
SUCCESS STORY
Headquartered in Montpelier, Cilcare is a French biotech company dedicated to the development of innovative therapies for inner ear diseases.
"Our partnership with CBSET is far more than a contractual relationship — it is a shared scientific engine that has driven some of our most important discoveries.” - Celia Belline, Cilcare Founder and CEO